Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis.

Author: Bomasang-LaynoEmily, FadlonIris, HimelhochSeth, MurrayAndrea N

Paper Details 
Original Abstract of the Article :
CONTEXT: Depression affects 50-70% of patients with Parkinson's disease resulting in significant comorbidity, executive dysfunction, and poorer quality of life. Divergent results from studies of different treatments preclude definite treatment recommendations. OBJECTIVE: To perform a systematic rev...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.parkreldis.2015.04.018

データ提供:米国国立医学図書館(NLM)

Antidepressant Treatments for Parkinson's Disease: A Camel's Journey Through Mental Health

This study examines the effectiveness of various pharmacologic, behavioral, and rTMS interventions for treating depression in patients with Parkinson's disease. It's like a camel seeking solace in a desert oasis, seeking relief from the challenges of a debilitating condition. The researchers conducted a meta-analysis of multiple randomized controlled trials to assess the efficacy of different treatment approaches, striving to find the most effective solutions.

A Camel's Perspective on Depression Relief

The study's findings suggest that antidepressant medications, specifically SSRIs, and behavioral interventions, particularly cognitive behavioral therapy (CBT), demonstrate significant efficacy in improving depression among Parkinson's disease patients. It's like a camel finding a hidden spring of hope in the desert, offering a path toward improved mental health and well-being.

From Therapy to Well-being: A Camel's Journey

This research highlights the importance of addressing mental health alongside physical health in Parkinson's disease patients. It encourages a multi-faceted approach to treatment, integrating pharmacologic, behavioral, and non-invasive therapies. It's like finding a hidden oasis of support, offering a holistic approach to managing the challenges of Parkinson's disease.

Dr. Camel's Conclusion

This meta-analysis underscores the importance of addressing depression in Parkinson's disease patients, highlighting the effectiveness of antidepressant medications and behavioral therapies. The findings encourage a multi-faceted approach to treatment, integrating various therapeutic interventions to improve mental health and overall well-being.
Date :
  1. Date Completed 2016-05-06
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

26037457

DOI: Digital Object Identifier

10.1016/j.parkreldis.2015.04.018

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.